RYAN STEVENSON: Open Payments
NPI 1861791964 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$819 in 41 payments from 10 companies in 2025. Trend: 2023 $1,068 · 2024 $1,019 · 2025 $819
Food & beverage: $819
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $508 |
| Novo Nordisk Inc | 13 | $153 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Lilly USA, LLC | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: QULIPTA, Ozempic, UBRELVY, Wegovy, Rybelsus, TRELEGY ELLIPTA, MOUNJARO, Auvelity.
Industry payments across MI — which companies pay providers there.
